|
SEPT8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.258500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.200100E-02 |
| Normal-vs-Stage2 |
3.658400E-01 |
| Normal-vs-Stage3 |
2.898200E-01 |
| Normal-vs-Stage4 |
1.978420E-01 |
| Stage1-vs-Stage2 |
6.096400E-01 |
| Stage1-vs-Stage3 |
5.674800E-01 |
| Stage1-vs-Stage4 |
8.502200E-01 |
| Stage2-vs-Stage3 |
9.834200E-01 |
| Stage2-vs-Stage4 |
5.814200E-01 |
| Stage3-vs-Stage4 |
5.441600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.620000E-02 |
| Normal-vs-AfricanAmerican |
3.076800E-01 |
| Normal-vs-Asian |
6.311000E-01 |
| Caucasian-vs-AfricanAmerican |
2.091400E-01 |
| Caucasian-vs-Asian |
1.675000E-01 |
| AfricanAmerican-vs-Asian |
3.065600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.733590E-02 |
| Normal-vs-Female |
8.671600E-01 |
| Male-vs-Female |
1.528240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.768200E-02 |
| Normal-vs-Extreme_Weight |
4.405600E-02 |
| Normal-vs-Obese |
2.300600E-01 |
| Normal-vs-Extreme_Obese |
6.638000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.590800E-01 |
| Normal_Weight-vs-Obese |
3.868600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.725400E-01 |
| Extreme_Weight-vs-Obese |
2.820400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.651200E-01 |
| Obese-vs-Extreme_Obese |
2.462000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.221200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.544400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.719100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.785700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.341800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.259610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.187900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.260460E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.972060E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.214800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.302300E-02 |
| Normal-VS-Type2 PRCC |
1.898370E-03 |
| Normal-VS-KIRP CIMP |
8.102800E-01 |
| Normal-VS-Unclassified PRCC |
6.368600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.292200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.961600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.491600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.848000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.941700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.020800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.608100E-02 |
| Normal-vs-N1 |
2.068400E-01 |
| Normal-vs-N2 |
3.750400E-01 |
| N0-vs-N1 |
3.276200E-01 |
| N0-vs-N2 |
9.358000E-01 |
| N1-vs-N2 |
6.836400E-01 |
|
|
